Up 111%: No one thought this ASX 200 stock would double in 2023, but it did

The QVG team still reckons there is more upside to this stock that exceeded even their expectations last year.

| More on:
Male building supervisor wearing high vis vest and hard hat stands and smiles with his arms crossed at a building site

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The harsh reality is that no one, even the most seasoned professional fund managers, know what will happen with stocks.

One classic example is James Hardie Industries plc (ASX: JHX), which is QVG Long-Short Fund's second largest holding.

The share price for construction materials maker has now rocketed more than 111% since Christmas Eve 2022.

Although the QVG analysts obviously bought the S&P/ASX 200 Index (ASX: XJO) shares thinking they would rise, even they were surprised at how the stock has performed.

"Building materials company James Hardie rose 16% in December taking its annual return to over 100%," read a memo to QVG clients.

"We could not have foreseen James Hardie doubling in a year when the 30-year fixed rate mortgage in the US touched a decade-high 7.8%."

'Conviction in the competitive advantages'

With still a substantial holding, the QVG team is still bullish on James Hardie despite the steep run-up in share price.

The conditions are just right for the company both internally and externally.

"James Hardie benefited from improved sentiment towards housing activity in its important US market," read the memo.

"Conviction in the competitive advantages of their product allowing it to be a long-term market share gainer helped us to hold the stock in the face of obvious macroeconomic headwinds."

The QVG analysts are not the only fans of James Hardie.

The CMC Invest broking platform currently shows 10 out of 14 analysts rate the ASX 200 stock as a buy.

Eight of those think it's a strong buy, despite the share price continuing to break 52-week highs.

The Motley Fool's Mitchell Lawler earlier this month pointed out that, within the ASX 200, James Hardie was one of the big winners of 2023 that did not show "stomach-churning volatility".

"The obvious perk of reduced volatility is less time feeling like your heart is in your throat. 

"Investing can induce emotionally charged decisions in even the most experienced partakers… If a company's share price tends to move slowly, it could mean a better night's sleep and a more rational approach."

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »